Clinical trial

Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With…

NCT00442767 · Montefiore Medical Center, Other · Completed

Key facts

NCT number NCT00442767
Title Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
Official title Reducing Postprandial Hyperglycemia With Adjuvant Premeal Pramlintide and Postmeal Insulin in Children With Type 1 Diabetes Mellitus.
Lead sponsor Montefiore Medical Center, Other
Collaborators Amylin Pharmaceuticals, LLC. Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Type 1 Diabetes Mellitus
Intervention type Drug
Interventions Insulin, Pramlintide + Insulin
Enrollment 8
Start date Feb 1, 2007
Primary completion Feb 1, 2009
Completion Feb 1, 2009
First posted Mar 2, 2007
Last update posted Jul 10, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies